9 Results for "

NMDA receptor NR2B subunit

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "NMDA receptor NR2B subunit" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-13993
CAS No.: 169274-78-6
Purity:  99.55%
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-13993A
CAS No.: 1312991-76-6
Purity:  99.25%
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 Maleate is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 Maleat shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 Maleate has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-145585
CAS No.: 1892581-29-1
Synonyms: MIJ-821
Target:  

iGluR

Research Areas:  

Neurological Disease

Onfasprodil (MIJ-821) is a selective intravenous NMDA receptor NR2B subunit negative allosteric modulator (NAM). Onfasprodil inhibits the activity of NR2B-NMDA receptors. Onfasprodil has a rapid antidepressant effect. Onfasprodil can be used for the research of treatment-resistant depression (TRD) .
loading...
    loading...
Cat. No.: HY-137049
CAS No.: 193359-26-1
Synonyms: PD 174494
Target:  

iGluR

Research Areas:  

Others

Co-101244 (PD 174494) is an NMDA receptor blocker that specifically targets the NR2B subunit.
loading...
    loading...
Cat. No.: HY-184055
CAS No.: 2643356-08-3
Target:  

iGluR

Research Areas:  

Neurological Disease

NMDA receptor antagonist-12 (Example 17) is an antagonist of NMDA receptors containing the NR2B subunit. NMDA receptor antagonist-12 exerts antagonistic effects on NMDA receptors containing the NR2B subunit and blocks the intracellular Ca 2+ influx mediated by these receptors. NMDA receptor antagonist-12 can be used in research related to diseases such as depression, bipolar disorder, migraine, and pain .
loading...
    loading...
Cat. No.: HY-136659
CAS No.: 194089-07-1
Target:  

iGluR

Research Areas:  

Others

Ro 04-5595 is a selective antagonist with specific activity against the NR2B subunit of the NMDA receptor. Ro 04-5595 exhibits favorable pharmacokinetic properties in in vitro and in vivo studies, with rapid uptake and clearance. Ro 04-5595 exhibits strong binding in NR2B receptor-enriched regions and low binding in the cerebellum. Ro 04-5595 is able to effectively inhibit specific binding, showing high affinity for the NR2B receptor and a clear ranking of binding affinity with a variety of other compounds .
loading...
    loading...
Cat. No.: HY-13993B
CAS No.: 919289-58-0
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 hydrochloride is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 hydrochloride shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 hydrochloride has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-107708
CAS No.: 1312991-83-5
threo Ifenprodil hemitartrate is a σ receptor agonist, with Kis of 59.1 and 2 nM for σ1 and σ2 receptors, respectively. threo Ifenprodil hemitartrate is also a NR2B subunit-selective NMDA receptor antagonist (IC50=0.22 μM). threo Ifenprodil hemitartrate is a hERG potassium channel inhibitor, with an IC 50 of 88 nM, showing antiarrhythmic activity .
loading...
    loading...
Cat. No.: HY-185027
CAS No.: 1402938-19-5
Research Areas:  

Neurological Disease

Memagal is an AchE inhibitor (IC50 = 1.16 nM) and a NMDAR antagonist (Ki = 4.6 μM). Memagal inhibits the neurotoxicity induced by NMDA (HY-17551), with its IC50 value being 0.28 nM. Memagal can be used for research on Alzheimer's disease .
loading...
    loading...